The US pharma giant seeks to regain profits through cancer treatment drugs since the demand for its Covid-19 vaccines has plummeted
The American drug manufacturer, Pfizer, views the cancer treatment market as a new Klondike now that the Covid-19 pandemic is over and the global demand for its vaccines and Covid drugs is falling, its CEO Albert Bourla told Fox Business on May 1.
The company expects to score big on “blockbuster” cancer drugs...